Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...
"Eucalyptus Terpenes (CAS 84625-32-1) Market provides a careful review of the sales forecast and trends for 2020-2026:
The latest and most recent report from Regal...